# pathway_0181

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **D** — Secondary metabolite biosynthesis. .

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MERIPASAGPEAIFEAFRRDGIIVIEGFLTPDQVQRFSSEVQPGLDELTVGAPEHDEAAQTATVMDEMIGEKTKRLGQLVTRSAVFRHELLEHELMHALLEKVFVEGPMDGYWMNASEVIEIAPGSNAQPIHRDQELYDVWNRAGPAMPEAICNFISALTPFTALNGATQVAPGTHRDFTSDHLLDRDFQGRSDLKTIPAVMNPGDCIFFSGKILHGGGANHTADELRRGLAMSFIRRILTPEEAHPLSVSREIVDTMTYRGQAMLGFRSQWPVIEGVPNFYWTHQGSEIGSHIGLKEKTSGSVVL

[Multiple Choices]
A. O-acetyl-L-homoserine from L-homoserine: step 1/1. .
B. Carbohydrate degradation
C. Protein biosynthesis
D. Secondary metabolite biosynthesis. .
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches a UniProt entry annotated as dioxygenase FrzG, with the pathway “Secondary metabolite biosynthesis.” The annotation cites experimental evidence from a paper on FR901483 biosynthesis, supporting choice D for this sequence.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence may suggest an enzyme, but the supplied sequence and choices do not establish its specific role in secondary-metabolite biosynthesis rather than another pathway.


**Missing item-specific fact**

> The protein-specific functional and pathway assignment connecting this enzyme to FR901483 biosynthesis.


**Reason**

> Choosing D depends on an item-specific pathway annotation or equivalent protein-specific knowledge not provided in the question. Recognizing the exact sequence would not constitute biological reasoning from the input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The evidence supports D; no other listed option is comparably supported. The limitation is that the pathway assignment is not meaningfully distinguishable from the supplied sequence alone.


### Important caveats

- The evidence is reviewer-only and was not available to the evaluated model.
- The matched UniProt entry and its pathway annotation are source-specific; the cited experimental evidence is not independently assessed here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence may suggest an enzyme, but the supplied sequence and choices do not establish its specific role in secondary-metabolite biosynthesis rather than another pathway.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional and pathway assignment connecting this enzyme to FR901483 biosynthesis.",
    "reason": "Choosing D depends on an item-specific pathway annotation or equivalent protein-specific knowledge not provided in the question. Recognizing the exact sequence would not constitute biological reasoning from the input."
  },
  "case_id": "pathway_0181",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence matches a UniProt entry annotated as dioxygenase FrzG, with the pathway “Secondary metabolite biosynthesis.” The annotation cites experimental evidence from a paper on FR901483 biosynthesis, supporting choice D for this sequence."
  },
  "important_caveats": [
    "The evidence is reviewer-only and was not available to the evaluated model.",
    "The matched UniProt entry and its pathway annotation are source-specific; the cited experimental evidence is not independently assessed here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence supports D; no other listed option is comparably supported. The limitation is that the pathway assignment is not meaningfully distinguishable from the supplied sequence alone."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0181",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches a UniProt entry annotated as dioxygenase FrzG, with the pathway “Secondary metabolite biosynthesis.” The annotation cites experimental evidence from a paper on FR901483 biosynthesis, supporting choice D for this sequence.",
    "evidence_ids": ["C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence may suggest an enzyme, but the supplied sequence and choices do not establish its specific role in secondary-metabolite biosynthesis rather than another pathway.",
    "missing_item_specific_fact": "The protein-specific functional and pathway assignment connecting this enzyme to FR901483 biosynthesis.",
    "reason": "Choosing D depends on an item-specific pathway annotation or equivalent protein-specific knowledge not provided in the question. Recognizing the exact sequence would not constitute biological reasoning from the input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence supports D; no other listed option is comparably supported. The limitation is that the pathway assignment is not meaningfully distinguishable from the supplied sequence alone."
  },
  "important_caveats": [
    "The evidence is reviewer-only and was not available to the evaluated model.",
    "The matched UniProt entry and its pathway annotation are source-specific; the cited experimental evidence is not independently assessed here."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt annotation (C5, H3) explicitly states PATHWAY: Secondary metabolite biosynthesis with evidence code ECO:0000269 (inferred from experiment), citing PubMed:33372776 (JACS 2021, Zhang et al., 'Biosynthesis of the Immunosuppressant (-)-FR901483'). The protein is Dioxygenase FrzG (EC 1.14.11.-), a Fe(II)/2-oxoglutarate-dependent dioxygenase in the FR901483 biosynthetic cluster of Cladobotryum sp. FR901483 is a fungal natural product (immunosuppressant), confirming secondary metabolite biosynthesis. Sequence match confirmed (SHA256 identical, 306 AA).

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains the HGGGANHT motif characteristic of Fe(II)/2-oxoglutarate-dependent dioxygenases (a 2-His-1-carboxylate facial triad). Option A (homoserine O-acetyltransferase) requires a GNAT-fold acetyltransferase, absent here. Option B (carbohydrate degradation) requires glycosidase/cellulase motifs, absent. Option C (protein biosynthesis) requires ribosomal or aminoacyl-tRNA synthetase features, absent. By elimination, D remains, and the dioxygenase motif is positively consistent with secondary metabolite biosynthesis, where Fe(II)/2-OG dioxygenases are prevalent (especially in fungal NRPS/PKS assembly-line modification).


**Missing item-specific fact**

> The organism (Cladobotryum sp., a fungus) is not provided in the input, weakening the general rule that fungal Fe(II)/2-OG dioxygenases are predominantly in secondary metabolite clusters. The specific FR901483 pathway identity requires database lookup.


**Reason**

> While the specific pathway name (FR901483 biosynthesis) requires lookup, the question is answerable by elimination of clearly mismatched options (A, B, C) combined with positive identification of a dioxygenase motif consistent with secondary metabolite biosynthesis. This constitutes a meaningful biological reasoning path, though the positive assignment is strengthened by organism context not provided in the input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, B, and C are clearly excluded by the absence of relevant enzyme-family motifs. Option D is the only remaining choice and is positively supported by the dioxygenase signature. No other option is defensible.


### Important caveats

- The organism context (fungal, Cladobotryum sp.) is not provided in the model input, making the general 'fungal dioxygenase → secondary metabolite' heuristic less directly applicable.
- The specific pathway (FR901483 biosynthesis) is a narrow fact requiring database lookup; the question's answer category ('Secondary metabolite biosynthesis') is broader and more amenable to reasoning.
- The evidence code ECO:0000269 confirms experimental support for the pathway annotation, not merely computational inference.
- The protein was integrated into Swiss-Prot in January 2026; the benchmark's author source snapshot date is unknown, but sequence and annotation are consistent across versions 11 and 13.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains the HGGGANHT motif characteristic of Fe(II)/2-oxoglutarate-dependent dioxygenases (a 2-His-1-carboxylate facial triad). Option A (homoserine O-acetyltransferase) requires a GNAT-fold acetyltransferase, absent here. Option B (carbohydrate degradation) requires glycosidase/cellulase motifs, absent. Option C (protein biosynthesis) requires ribosomal or aminoacyl-tRNA synthetase features, absent. By elimination, D remains, and the dioxygenase motif is positively consistent with secondary metabolite biosynthesis, where Fe(II)/2-OG dioxygenases are prevalent (especially in fungal NRPS/PKS assembly-line modification).",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "The organism (Cladobotryum sp., a fungus) is not provided in the input, weakening the general rule that fungal Fe(II)/2-OG dioxygenases are predominantly in secondary metabolite clusters. The specific FR901483 pathway identity requires database lookup.",
    "reason": "While the specific pathway name (FR901483 biosynthesis) requires lookup, the question is answerable by elimination of clearly mismatched options (A, B, C) combined with positive identification of a dioxygenase motif consistent with secondary metabolite biosynthesis. This constitutes a meaningful biological reasoning path, though the positive assignment is strengthened by organism context not provided in the input."
  },
  "case_id": "pathway_0181",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt annotation (C5, H3) explicitly states PATHWAY: Secondary metabolite biosynthesis with evidence code ECO:0000269 (inferred from experiment), citing PubMed:33372776 (JACS 2021, Zhang et al., 'Biosynthesis of the Immunosuppressant (-)-FR901483'). The protein is Dioxygenase FrzG (EC 1.14.11.-), a Fe(II)/2-oxoglutarate-dependent dioxygenase in the FR901483 biosynthetic cluster of Cladobotryum sp. FR901483 is a fungal natural product (immunosuppressant), confirming secondary metabolite biosynthesis. Sequence match confirmed (SHA256 identical, 306 AA)."
  },
  "important_caveats": [
    "The organism context (fungal, Cladobotryum sp.) is not provided in the model input, making the general 'fungal dioxygenase → secondary metabolite' heuristic less directly applicable.",
    "The specific pathway (FR901483 biosynthesis) is a narrow fact requiring database lookup; the question's answer category ('Secondary metabolite biosynthesis') is broader and more amenable to reasoning.",
    "The evidence code ECO:0000269 confirms experimental support for the pathway annotation, not merely computational inference.",
    "The protein was integrated into Swiss-Prot in January 2026; the benchmark's author source snapshot date is unknown, but sequence and annotation are consistent across versions 11 and 13."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C are clearly excluded by the absence of relevant enzyme-family motifs. Option D is the only remaining choice and is positively supported by the dioxygenase signature. No other option is defensible."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0181",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt annotation (C5, H3) explicitly states PATHWAY: Secondary metabolite biosynthesis with evidence code ECO:0000269 (inferred from experiment), citing PubMed:33372776 (JACS 2021, Zhang et al., 'Biosynthesis of the Immunosuppressant (-)-FR901483'). The protein is Dioxygenase FrzG (EC 1.14.11.-), a Fe(II)/2-oxoglutarate-dependent dioxygenase in the FR901483 biosynthetic cluster of Cladobotryum sp. FR901483 is a fungal natural product (immunosuppressant), confirming secondary metabolite biosynthesis. Sequence match confirmed (SHA256 identical, 306 AA).",
    "evidence_ids": ["C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains the HGGGANHT motif characteristic of Fe(II)/2-oxoglutarate-dependent dioxygenases (a 2-His-1-carboxylate facial triad). Option A (homoserine O-acetyltransferase) requires a GNAT-fold acetyltransferase, absent here. Option B (carbohydrate degradation) requires glycosidase/cellulase motifs, absent. Option C (protein biosynthesis) requires ribosomal or aminoacyl-tRNA synthetase features, absent. By elimination, D remains, and the dioxygenase motif is positively consistent with secondary metabolite biosynthesis, where Fe(II)/2-OG dioxygenases are prevalent (especially in fungal NRPS/PKS assembly-line modification).",
    "missing_item_specific_fact": "The organism (Cladobotryum sp., a fungus) is not provided in the input, weakening the general rule that fungal Fe(II)/2-OG dioxygenases are predominantly in secondary metabolite clusters. The specific FR901483 pathway identity requires database lookup.",
    "reason": "While the specific pathway name (FR901483 biosynthesis) requires lookup, the question is answerable by elimination of clearly mismatched options (A, B, C) combined with positive identification of a dioxygenase motif consistent with secondary metabolite biosynthesis. This constitutes a meaningful biological reasoning path, though the positive assignment is strengthened by organism context not provided in the input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C are clearly excluded by the absence of relevant enzyme-family motifs. Option D is the only remaining choice and is positively supported by the dioxygenase signature. No other option is defensible."
  },
  "important_caveats": [
    "The organism context (fungal, Cladobotryum sp.) is not provided in the model input, making the general 'fungal dioxygenase → secondary metabolite' heuristic less directly applicable.",
    "The specific pathway (FR901483 biosynthesis) is a narrow fact requiring database lookup; the question's answer category ('Secondary metabolite biosynthesis') is broader and more amenable to reasoning.",
    "The evidence code ECO:0000269 confirms experimental support for the pathway annotation, not merely computational inference.",
    "The protein was integrated into Swiss-Prot in January 2026; the benchmark's author source snapshot date is unknown, but sequence and annotation are consistent across versions 11 and 13."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A7T8F1J7` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 11. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1J7.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:45.181011+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"FR901483 biosynthesis clusters protein G"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"1.14.11.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"Dioxygenase FrzG"}}}
```

Source SHA-256: `1b4c93baaffd12970b2ec727fed458c9980728a465bf164a4f6d113596d18a2c`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1J7.json)  
**Locator:** `/comments/3`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:45.181011+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"Secondary metabolite biosynthesis"}]}
```

Source SHA-256: `1b4c93baaffd12970b2ec727fed458c9980728a465bf164a4f6d113596d18a2c`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1J7.json)  
**Locator:** `/references/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:45.181011+00:00.  

```json
{"citation":{"authors":["Zhang Z.","Tamura Y.","Tang M.","Qiao T.","Sato M.","Otsu Y.","Sasamura S.","Taniguchi M.","Watanabe K.","Tang Y."],"citationCrossReferences":[{"database":"PubMed","id":"33372776"},{"database":"DOI","id":"10.1021/jacs.0c12352"}],"citationType":"journal article","firstPage":"132","id":"33372776","journal":"J. Am. Chem. Soc.","lastPage":"136","publicationDate":"2021","title":"Biosynthesis of the Immunosuppressant (-)-FR901483.","volume":"143"},"referenceComments":[{"type":"STRAIN","value":"11231"}],"referenceNumber":1,"referencePositions":["NUCLEOTIDE SEQUENCE [GENOMIC DNA]","FUNCTION","CATALYTIC ACTIVITY","PATHWAY"]}
```

Source SHA-256: `1b4c93baaffd12970b2ec727fed458c9980728a465bf164a4f6d113596d18a2c`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1J7?format=txt&versions=11)  
**Locator:** `lines 1-13`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-02T04:25:47.145944+00:00.  

```text
ID   FRZG_CLASX              Reviewed;         306 AA.
AC   A0A7T8F1J7;
DT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.
DT   02-JUN-2021, sequence version 1.
DT   28-JAN-2026, entry version 11.
DE   RecName: Full=Dioxygenase FrzG {ECO:0000303|PubMed:33372776};
DE            EC=1.14.11.- {ECO:0000269|PubMed:33372776};
DE   AltName: Full=FR901483 biosynthesis clusters protein G {ECO:0000303|PubMed:33372776};
GN   Name=FrzA {ECO:0000303|PubMed:33372776};
OS   Cladobotryum sp.
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC   Hypocreomycetidae; Hypocreales; Hypocreaceae; Cladobotryum.
OX   NCBI_TaxID=2040732;
```

Source SHA-256: `f7220d1dfc16f94bbf8f0f9c40fe6b41a3e5a34c18117de584665dd38e84aa5a`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1J7?format=txt&versions=11)  
**Locator:** `lines 14-22`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-02T04:25:47.145944+00:00.  

```text
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RC   STRAIN=11231;
RX   PubMed=33372776; DOI=10.1021/jacs.0c12352;
RA   Zhang Z., Tamura Y., Tang M., Qiao T., Sato M., Otsu Y., Sasamura S.,
RA   Taniguchi M., Watanabe K., Tang Y.;
RT   "Biosynthesis of the Immunosuppressant (-)-FR901483.";
RL   J. Am. Chem. Soc. 143:132-136(2021).
```

Source SHA-256: `f7220d1dfc16f94bbf8f0f9c40fe6b41a3e5a34c18117de584665dd38e84aa5a`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1J7?format=txt&versions=11)  
**Locator:** `lines 67-68`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-02T04:25:47.145944+00:00.  

```text
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000269|PubMed:33372776}.
```

Source SHA-256: `f7220d1dfc16f94bbf8f0f9c40fe6b41a3e5a34c18117de584665dd38e84aa5a`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 181. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
